Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial - Wilke, H; Muro, K; Van Cutsem, E (Lancet Oncol, 2014)
et al.